Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age
- PMID: 33686965
- PMCID: PMC8034891
- DOI: 10.18632/aging.202637
Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age
Abstract
This study compared the clinicopathological characteristics and survival of patients with metastatic renal cell carcinoma (mRCC) stratified by age to identify clinical features and prognostic factors. Patients with renal cell carcinoma (RCC) between 2010 and 2015 were identified from the Surveillance, Epidemiology and End Results database. Age was an independent prognostic factor for patients with RCC, mRCC, mRCC of clear cell renal cell carcinoma and lung-related metastases. There were many significant differences between the younger and older groups, including differences in marital status, race, sex, year of diagnosis, histology grade, laterality, T stage, N stage, tumor size, type of treatment, including surgery, radiation or chemotherapy, and pattern of organic metastasis to the liver, lung, or brain (P<0.05). Moreover, different natural metastasis patterns and poorer overall survival were observed in the older group compared with the younger group (P<0.05). Parameters, including marital status, sex, year of diagnosis, histological grade, N stage, surgery, chemotherapy, lung metastasis and liver metastasis, were independent prognostic factors for elderly patients (P<0.05). Age plays a significant role in mRCC, and elderly patients with mRCC are a special group of individuals whose clinical characteristics and prognostic factors are different from those of younger patients; therefore, these patients require special attention.
Keywords: elderly patients; metastasis; prognostic factors; renal cell carcinoma; survival.
Conflict of interest statement
Figures



Similar articles
-
Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.Cancer Med. 2019 Sep;8(12):5629-5637. doi: 10.1002/cam4.2484. Epub 2019 Aug 12. Cancer Med. 2019. PMID: 31407495 Free PMC article.
-
The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database.Sci Rep. 2021 Sep 8;11(1):17822. doi: 10.1038/s41598-021-97365-6. Sci Rep. 2021. PMID: 34497343 Free PMC article.
-
Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database.J Korean Med Sci. 2024 Nov 25;39(45):e293. doi: 10.3346/jkms.2024.39.e293. J Korean Med Sci. 2024. PMID: 39592128 Free PMC article.
-
Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.Clin Genitourin Cancer. 2019 Feb;17(1):e32-e37. doi: 10.1016/j.clgc.2018.08.005. Epub 2018 Aug 28. Clin Genitourin Cancer. 2019. PMID: 30268423 Review.
-
Treatment of elderly patients with metastatic renal cell carcinoma.Expert Rev Anticancer Ther. 2016;16(3):323-34. doi: 10.1586/14737140.2016.1131613. Epub 2016 Jan 20. Expert Rev Anticancer Ther. 2016. PMID: 26654225 Review.
Cited by
-
Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.Cancer Control. 2022 Jan-Dec;29:10732748221121226. doi: 10.1177/10732748221121226. Cancer Control. 2022. PMID: 35981235 Free PMC article.
-
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.Biomedicines. 2024 May 16;12(5):1111. doi: 10.3390/biomedicines12051111. Biomedicines. 2024. PMID: 38791072 Free PMC article. Review.
-
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.Front Oncol. 2023 Aug 16;13:1223282. doi: 10.3389/fonc.2023.1223282. eCollection 2023. Front Oncol. 2023. PMID: 37664025 Free PMC article.
-
Risk Factors, Prognostic Factors, and Nomograms for Bone Metastasis in Patients with Newly Diagnosed Clear Cell Renal Cell Carcinoma: A Large Population-Based Study.Front Surg. 2022 Apr 1;9:877653. doi: 10.3389/fsurg.2022.877653. eCollection 2022. Front Surg. 2022. PMID: 35433803 Free PMC article.
-
Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database.Transl Cancer Res. 2023 Jun 30;12(6):1411-1421. doi: 10.21037/tcr-22-2692. Epub 2023 Jun 9. Transl Cancer Res. 2023. PMID: 37434676 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical